Calamos Advisors’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Calamos Advisors's EQHA.WS Position: Q4 2022 in Review

Calamos Advisors sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 150,350 shares — an estimated $13K sold.

Calamos Advisors first reported a position in EQHA.WS in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

• Calamos Advisors reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
• Calamos Advisors sold 150,350 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $13K.
• Calamos Advisors first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
• Calamos Advisors's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $13K in Q3 2022.
• 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.